Advertisement

Identification of fungal metabolites of anticonvulsant drug carbamazepine

  • Su-Il Kang
  • Seo-Young Kang
  • Hor-Gil Hur
Environmental Biotechnology

Abstract

Carbamazepine, which has been used in the treatments of epilepsy, is often found in the environment. Although metabolism of carbamazepine by humans and rats has been characterized, the environmental fate of carbamazepine has not been studied. In this study, two model fungi Cunninghamella elegans ATCC 9245 and Umbelopsis ramanniana R-56, which have previously shown diverse metabolic activities, were tested for metabolism of carbamazepine. Both fungi produced three metabolites each (C1–C3 and M1–M3). All six metabolites showed [M + H]+ at m/z 253, suggesting addition of one oxygen to the parent compound. High-performance liquid chromatography and liquid chromatography–mass spectrometric analysis detected 10, 11-dihydro-10, 11-epoxycarbamazepine as a major product (C3 (47%) and M3 (85%)) and 3-hydroxycarbamazepine (C2 (15%) and M2 (7%)) from carbamazepine through mixed mono-oxidation reactions in both fungal strains. C. elegans was confirmed to produce 2-hydroxycarbamazepine (C1 (38%)) while U. ramanniana produced a yet unidentified ring-hydroxylated metabolite (M1 (8%)). The current study suggests that carbamazepine is likely to be subjected to initially diverse mono-oxygenation reactions by fungal metabolisms, resulting in the formation of the corresponding metabolites, which were similarly found in mammalian metabolisms.

Keywords

Carbamazepine Cunninghamella elegans Umbelopsis ramanniana Epoxidation Mono-oxygenation 

Notes

Acknowledgements

This study was funded by United Nations University and Gwangju Institute of Science and Technology (GIST) Joint Program on Science and Technology for Sustainability, GIST and a grant from the MOST/KOSEF to the Environmental Biotechnology National Core Research Center (Grant #: R15-2003-012-02002-0), Gyoungsang National University, Korea.

References

  1. Azerad R (1999) Microbial models for drug metabolism. Adv Biochem Eng Biotech 63:169–218Google Scholar
  2. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E (2006) Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40:357–363CrossRefGoogle Scholar
  3. Duhart BTJ, Zhang D, Deck J, Freeman JP, Cerniglia CE (1999) Biotransformation of protriptyline by filamentous fungi and yeasts. Xenobiotica 29:733–746CrossRefGoogle Scholar
  4. Faigle JW, Feldmann KF (1989) Carbamazepine. Chemistry and biotransformation. In: Levy R, Mattson R, Meldrum BS, Penry JK, Dreifuss FE (eds) Antiepiletic drugs. 3rd edn. Raven, New York, pp 499–513Google Scholar
  5. Faigle JW, Feldmann KF (1995) Carbamazepine. Chemistry and biotransformation. In: Levy R, Mattson R, Meldrum BS (eds) Antiepiletic drugs. 4th edn. Raven, New York, pp 499–513Google Scholar
  6. Han GH, Hur HG, Kim SD (2006) Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna. Environ Toxicol Chem 25:265–271CrossRefGoogle Scholar
  7. Hufford CD, Capiton GA, Clark AM, Baker JK (1981) Metabolism of imipramine by microorganisms. J Pharma Sci 70:151–155CrossRefGoogle Scholar
  8. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FL, Levy RH (1994) Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 47:1969–1979CrossRefGoogle Scholar
  9. Kittelmann M, Lattmann R, Ghisalba O (1993) Preparation of 10,11-epoxy-carbamazepine and 10,11-dihydro-10-hydroxy-carbamazepine by microbial epoxidation and hydroxylation. Biosci Biotechnol Biochem 57:1589–1590CrossRefGoogle Scholar
  10. Kitteringham NR, Davis C, Howard N, Pirmohamed M, Park BK (1996) Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10,11-epoxide and naphthalene. J Pharmacol Exp Ther 278:1018–1027Google Scholar
  11. Lertratanangkoon K, Horning MG (1982) Metabolism of carbamazepine. Drug Metab Dispos 10:1–10Google Scholar
  12. Loffler D, Rombke J, Meller M, Ternes T (2005) Environmental fate of pharmaceuticals in water/sediment systems. Environ Sci Technol 39:5209–5218CrossRefGoogle Scholar
  13. Lynn RK, Smith RG, Thompson RM, Deinzer ML, Griffin D, Gerber N (1978) Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry. Drug Metab Dispos 6:494–501Google Scholar
  14. Maggs JL, Pirmohamed M, Kitteringham NR, Park BK (1997) Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Drug Metab Dispos 25:275–280Google Scholar
  15. Miao X, Metcalfe CD (2003) Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography–electrospray tandem mass spectrometry. Anal Chem 75:3731–3738CrossRefGoogle Scholar
  16. Moody JD, Freeman JP, Cerniglia CE (1999) Biotransformation of doxepin by Cunninghamella elegans. Drug Metab Dispos 27:1157–1164Google Scholar
  17. Myllynen P, Pienimaki P, Raunio H, Vahakangas K (1998) Microsomal metabolism of carbamazepine and oxcarbamazepine in liver and placenta. Human Exp Toxicol 17:668–676CrossRefGoogle Scholar
  18. Ogawa Y, Suda A, Kusama-Eguchi K, Watanabe K, Tokumasu S (2005) Interspecific groups of Umbelopsis ramanniana inferred from nucleotide sequences of nuclear rDNA transcribed spacer regions and sporangiospore morphology. Mycoscience 46:343–351CrossRefGoogle Scholar
  19. Parshikov IA, Freeman JP, Lay JO Jr, Beger RD, Williams AJ, Sutherland JB (1999) Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol Lett 177:131–135CrossRefGoogle Scholar
  20. Parshikov IA, Freeman JP, Lay JO Jr, Beger RD, Williams AJ, Sutherland JB (2000) Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus. Appl Environ Microbiol 66:2664–2667CrossRefGoogle Scholar
  21. Parshikov IA, Miriyala B, Muraleedharan K, Illendula A, Avery M, Williams J (2005) Biocatalysis of the antimalarial artemisinin by Mucor ramannianus strains. Pharma Biol 43:579–582CrossRefGoogle Scholar
  22. Pelkonen O, Myllynen P, Taavitsainen P, Boobis AR, Watts P, Lake BG, Price RJ, Renwick AB, Gomez-Lechon MJ, Castell JV, Ingelman-Sundberg M, Hidestrand M, Guillouzo A, Corcos L, Goldfarb PS, Lewis DF (2001) Carbamazepine: a ‘blind’ assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica 31:321–343CrossRefGoogle Scholar
  23. Seo J, Lee Y-G, Kim S-D, Cha C-J, Ahn J-H, Hur H-G (2005) Biodegradation of the insecticide N,N,-Diethyl-m-toluamide by fungi: identification and toxicity of metabolites. Arch Environ Contam Toxicol 48:323–328CrossRefGoogle Scholar
  24. Seo J, Jeon J, Kim S-D, Kang S, Han J, Hur H-G (2007) Fungal biodegradation of carbofuran and carbofuran phenol by the fungus Mucor ramannianus: identification of metabolites. Water Sci Technol 55:163–167Google Scholar
  25. Staines AG, Michael WHC, Burchell B (2004) N-Glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. J Pharmacol Exp Ther 311:1131–1137CrossRefGoogle Scholar
  26. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260CrossRefGoogle Scholar
  27. Tixier C, Singer H, Oellers S, Muller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen and naproxen in surface waters. Environ Sci Technol 37:1061–1068CrossRefGoogle Scholar
  28. Valentine CR, Valentine JL, Seng J, Leakey J, Casciano D (1996) The use of transgenic cell lines for evaluating toxic metabolites of carbamazepine. Cell Biol Toxicol 12:155–165CrossRefGoogle Scholar
  29. Zhang D, Evans FE, Freeman JP, Duhart BJR, Cerniglia CE (1995) Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metab Dispos 23:1417–1425Google Scholar
  30. Zhang D, Evans FE, Freeman JP, Yang Y, Deck J, Cerniglia CE (1996a) Formation of mammalian metabolites of cyclobenzaprine by the fungus, Cunninghamella elegans. Chem Biol Interactions 102:79–92CrossRefGoogle Scholar
  31. Zhang D, Hansen EB, Deck JJR, Heinze TM, Sutherland JB, Cerniglia CE (1996b) Fungal biotransformation of the antihistamine azatadine by Cunninghamella elegans. Appl Environ Microbiol 62:3477–3479Google Scholar
  32. Zhang D, Yifan Y, Leakey JEA, Cerniglia CE (1996c) Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Micobiol Lett 138:221–226CrossRefGoogle Scholar
  33. Zhang D, Hansen EB, Deck JJR, Heinze TM, Henderson A, Korfmacher WA, Cerniglia CE (1997) Fungal transformation of antihistamines: metabolism of cyproheptadine hydrochloride by Cunninghamella elegans. Xenobiotica 27:310–315CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.International Environmental Research CenterGwangju Institute of Science and TechnologyGwangjuKorea
  2. 2.Department of Environmental Science and EngineeringGwangju Institute of Science and TechnologyGwangjuKorea

Personalised recommendations